Publicacions en col·laboració amb investigadors/es de Universidad Autónoma de Madrid (10)

2018

  1. Vascular dysfunction in obese diabetic db/db mice involves the interplay between aldosterone/mineralocorticoid receptor and Rho kinase signaling

    Scientific Reports, Vol. 8, Núm. 1

2010

  1. Altered arachidonic acid metabolism via COX-1 and COX-2 contributes to the endothelial dysfunction of penile arteries from obese Zucker rats

    British Journal of Pharmacology, Vol. 159, Núm. 3, pp. 604-616

  2. Enhanced cyclooxygenase 2-mediated vasorelaxation in coronary arteries from insulin-resistant obese Zucker rats

    Atherosclerosis, Vol. 213, Núm. 2, pp. 392-399

2009

  1. Differential structural and functional changes in penile and coronary arteries from obese Zucker rats

    American Journal of Physiology - Heart and Circulatory Physiology, Vol. 297, Núm. 2

2006

  1. Effects of antagonists for endothelin ETA and ETB receptors on coronary endothelial and myocardial function after ischemia-reperfusion in anesthetized goats

    Vascular Pharmacology, Vol. 44, Núm. 5, pp. 384-390

  2. Goat cerebrovascular reactivity to ADP after ischemia-reperfusion. Role of nitric oxide, prostanoids and reactive oxygen species

    Brain Research, Vol. 1120, Núm. 1, pp. 114-123

  3. Vasoconstrictor prostanoids may be involved in reduced coronary reactive hyperemia after ischemia-reperfusion in anesthetized goats

    European Journal of Pharmacology, Vol. 530, Núm. 3, pp. 234-242

2005

  1. Effect of ischemia duration and nitric oxide on coronary vasoconstriction after ischemia-reperfusion

    European Journal of Pharmacology, Vol. 509, Núm. 2-3, pp. 165-170

  2. Enhanced response of pig coronary arteries to endothelin-1 after ischemia-reperfusion. Role of endothelin receptors, nitric oxide and prostanoids

    European Journal of Pharmacology, Vol. 524, Núm. 1-3, pp. 102-110

  3. Mechanisms of the protective effects of urocortin on coronary endothelial function during ischemia-reperfusion in rat isolated hearts

    British Journal of Pharmacology, Vol. 145, Núm. 4, pp. 490-494